Our Medicines

We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. We are investing billions in Research and Development (R&D), which includes the discovery and development of new medicines.

Our Medicines

OPDYTA® (Nivolumab)


YERVOI® (Ipilimumab)


ROJUZDA®  (Luspatercept)


 



NO-IN-2300007
Expiry 30 October 2025